In Investing RAD Doses 1st Patient in Therapeutic Trial of 177Lu-RAD202 June 4, 2025 No Comments Radiopharm Theranostics (RAD:AU) has announced RAD Doses 1st Patient in Therapeutic Trial of 177Lu-RAD202 Download the PDF here. This post appeared first on investingnews.com 0 Author Related Posts Bold Ventures Announces Further Increase of Non-brokered Private Placement June 5, 2025 Metals Focus: Gold to Average US$3,210 in 2025 as Central Banks Buy and Trade Tensions Grow June 5, 2025 Prismo Metals Appoints Gordon Aldcorn as President June 5, 2025
Metals Focus: Gold to Average US$3,210 in 2025 as Central Banks Buy and Trade Tensions Grow June 5, 2025